Gönül Aslan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gönül Aslan has a total of 237 co-authors. Here are the top co-authors by number of shared publications:
- Seda Tezcan Ülger
Department of Medical Microbiology, Faculty of Medicine, Mersin University, Mersin 33343, Turkey
23 shared publications - Taylan Bozok
Department of Medical Microbiology, Faculty of Medicine, Mersin University, 33343 Mersin, Türkiye
14 shared publications - Mahmut Ülger
Mersin University
10 shared publications - Harun Gülbudak
Department of Biology, Faculty of Science, Mersin University, Mersin, Turkiye
8 shared publications - Leyla Ersoy
Faculty of Medicine, Medical Microbiology, Mersin University, Mersin, Türkiye
7 shared publications - Hamide Kaya
Mersin Universitesi
6 shared publications
Latest Publications
- 17 November 2026
- Published by Academician Publishing
- p. 295-306
Klinik Örneklerin Yönetimi
- 17 November 2026
- Published by Academician Publishing
- p. 109-122
Lepra İmmünopatogenezi
- 17 November 2026
- Published by Academician Publishing
Mikobakteriler
- 1 May 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (5) , 458-463
Molecular and phenotypic evaluation of carbapenem resistance in Pseudomonas aeruginosa strains isolated from hospital infections
Aim This study was planned to investigate the resistance pattern of P. aeruginosa isolated from nosocomial specimens and to find the most appropriate method to detect metallo-beta-lactamase resistance by comparing the MBL E-test and Modified Hodge test with PCR. Methods In this study, 29 P. aeruginosa strains isolated from various clinics between June 2010 to June 2012 at Mersin University Research and Application Hospital, which were considered to be the causative agents of nosocomial infection according to CDC criteria and were considered to be resistant to carbapenem group antibiotics, were analyzed. Antibiotic susceptibility tests, metallo-beta-lactamase E-test, modified Hodge test, and polymerase chain reaction (PCR) tests were performed. In statistical analyses, the relationships between categorical data were analyzed using Chi-square or Likelihood Ratio test statistics. Results As a result of PCR experiments, the VIM-1 gene region responsible for metallo β-lactamase production was isolated in 11 (37.9%). strains IMP-1, IMP-2 and VIM-2 gene regions were negative. Conclusion The results obtained in our study are consistent with other studies in Turkey and around the world. It is concluded that there is a need for well-standardized phenotypic tests with well-defined evaluation criteria and genotypic confirmation of these tests to reveal MBL production.
- 1 May 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (5) , 458-463
Molecular and phenotypic evaluation of carbapenem resistance in Pseudomonas aeruginosa strains isolated from hospital infections
Aim This study was planned to investigate the resistance pattern of P. aeruginosa isolated from nosocomial specimens and to find the most appropriate method to detect metallo-beta-lactamase resistance by comparing the MBL E-test and Modified Hodge test with PCR. Methods In this study, 29 P. aeruginosa strains isolated from various clinics between June 2010 to June 2012 at Mersin University Research and Application Hospital, which were considered to be the causative agents of nosocomial infection according to CDC criteria and were considered to be resistant to carbapenem group antibiotics, were analyzed. Antibiotic susceptibility tests, metallo-beta-lactamase E-test, modified Hodge test, and polymerase chain reaction (PCR) tests were performed. In statistical analyses, the relationships between categorical data were analyzed using Chi-square or Likelihood Ratio test statistics. Results As a result of PCR experiments, the VIM-1 gene region responsible for metallo β-lactamase production was isolated in 11 (37.9%). strains IMP-1, IMP-2 and VIM-2 gene regions were negative. Conclusion The results obtained in our study are consistent with other studies in Turkey and around the world. It is concluded that there is a need for well-standardized phenotypic tests with well-defined evaluation criteria and genotypic confirmation of these tests to reveal MBL production.
- Open Access
- 30 March 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (4) , 354
Quantitative Evaluation of the Inhibitory Effects of Commercially Available Probiotics on Dual-Species Biofilms in Root Canals: A qPCR-Based Short-Term In Vitro Study
Objectives: To quantitatively evaluate the inhibitory effects of commercially available probiotic formulations (Probien, Enterogermina, Reflor) applied as intracanal medicaments against mature dual-species biofilms of Enterococcus faecalis (E. faecalis) and Candida albicans (C. albicans) using a qPCR-based in vitro root canal model, with calcium hydroxide included as the reference intracanal medicament for comparison. Materials and Methods: Root canal specimens containing mature dual-species biofilms were medicated with probiotic–poloxamer gel formulations (Probien, Enterogermina, or Reflor) or calcium hydroxide (reference inhibitory control); infected but untreated canals served as the non-inhibitory control, and sterile non-inoculated specimens were included to confirm procedural sterility. After a 7-day intracanal application period, microbial loads were quantified at baseline and post-treatment by qPCR, and results were expressed as delta cycle threshold (ΔCt), colony-forming equivalents (CFE/mL), and percentage reduction values. Results: A total of 78 specimens (n = 13 per group) were analyzed. No significant intergroup differences were found in E. faecalis ΔCt or reduction percentages (p > 0.05), indicating its persistence despite intracanal medication. For C. albicans, differences among groups were significant (p < 0.001). Calcium hydroxide showed the strongest antifungal effect, producing marked ΔCt and CFE reductions versus probiotic and positive control groups, whereas probiotic formulations displayed only limited antifungal activity and no measurable inhibition against E. faecalis. Conclusions: Under the conditions of this in vitro model, the tested commercially available probiotic formulations—originally developed for gastrointestinal use—did not demonstrate significant antimicrobial effects against mature E. faecalis–C. albicans biofilms. These findings should be interpreted in the context of the absence of probiotic formulations specifically designed for intracanal use and the distinct ecological characteristics of the root canal system, which represents a closed, low-oxygen environment dominated by hard-tissue surfaces. Rather than excluding the potential of probiotics in endodontics, the present results highlight the need for root canal–adapted probiotic strains and delivery strategies tailored to intracanal conditions. Clinical Relevance: This in vitro study provides experimental insight into the limitations of directly applying commercially available gastrointestinal probiotic formulations within the root canal system. The findings highlight the importance of developing root canal–specific probiotic strains and delivery strategies tailored to the unique ecological conditions of the intracanal environment, thereby informing future translational and experimental research in biological endodontics.
- 30 March 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (4) , 354
Open AccessQuantitative Evaluation of the Inhibitory Effects of Commercially Available Probiotics on Dual-Species Biofilms in Root Canals: A qPCR-Based Short-Term In Vitro Study
Objectives: To quantitatively evaluate the inhibitory effects of commercially available probiotic formulations (Probien, Enterogermina, Reflor) applied as intracanal medicaments against mature dual-species biofilms of Enterococcus faecalis (E. faecalis) and Candida albicans (C. albicans) using a qPCR-based in vitro root canal model, with calcium hydroxide included as the reference intracanal medicament for comparison. Materials and Methods: Root canal specimens containing mature dual-species biofilms were medicated with probiotic–poloxamer gel formulations (Probien, Enterogermina, or Reflor) or calcium hydroxide (reference inhibitory control); infected but untreated canals served as the non-inhibitory control, and sterile non-inoculated specimens were included to confirm procedural sterility. After a 7-day intracanal application period, microbial loads were quantified at baseline and post-treatment by qPCR, and results were expressed as delta cycle threshold (ΔCt), colony-forming equivalents (CFE/mL), and percentage reduction values. Results: A total of 78 specimens (n = 13 per group) were analyzed. No significant intergroup differences were found in E. faecalis ΔCt or reduction percentages (p > 0.05), indicating its persistence despite intracanal medication. For C. albicans, differences among groups were significant (p < 0.001). Calcium hydroxide showed the strongest antifungal effect, producing marked ΔCt and CFE reductions versus probiotic and positive control groups, whereas probiotic formulations displayed only limited antifungal activity and no measurable inhibition against E. faecalis. Conclusions: Under the conditions of this in vitro model, the tested commercially available probiotic formulations—originally developed for gastrointestinal use—did not demonstrate significant antimicrobial effects against mature E. faecalis–C. albicans biofilms. These findings should be interpreted in the context of the absence of probiotic formulations specifically designed for intracanal use and the distinct ecological characteristics of the root canal system, which represents a closed, low-oxygen environment dominated by hard-tissue surfaces. Rather than excluding the potential of probiotics in endodontics, the present results highlight the need for root canal–adapted probiotic strains and delivery strategies tailored to intracanal conditions. Clinical Relevance: This in vitro study provides experimental insight into the limitations of directly applying commercially available gastrointestinal probiotic formulations within the root canal system. The findings highlight the importance of developing root canal–specific probiotic strains and delivery strategies tailored to the unique ecological conditions of the intracanal environment, thereby informing future translational and experimental research in biological endodontics.
- 24 December 2025
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 30 (4) , 466-472
High Prevalence of rtxA, enhC, and mip Genes in Waterborne Legionella Isolates
- 24 December 2025
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 30 (4) , 466-472
High Prevalence of rtxA, enhC, and mip Genes in Waterborne Legionella Isolates
- 2 December 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 211, 108211
Synergistic interaction between tuberculosis and depression: Changes in miRNA expression
- 2 December 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 211, 108211
Synergistic interaction between tuberculosis and depression: Changes in miRNA expression
- 11 October 2025
- Published by Springer Nature in Folia Microbiologica
- p. 1-8
Evaluation of the interaction and synergy potential of bedaquiline and clarithromycin in combination with efflux pump inhibitors in clinical isolates of Mycobacterium abscessus complex
Nontuberculous mycobacteria (NTM) cause difficult-to-treat pulmonary infections due to their high antimicrobial resistance. Among them, the Mycobacterium abscessus complex (MABC) is a major pathogen characterized by prolonged treatment courses and low success rates. This study investigated the combination effects of the antimicrobials bedaquiline (BDQ) and clarithromycin (CLA) with the efflux pump inhibitors (EPIs) verapamil (VP) and berberine (BER) in clinical MABC isolates. Nineteen MABC strains isolated from respiratory samples were analyzed using the checkerboard method, and fractional inhibitory concentration index (FICI) values were calculated to determine synergistic, indifferent, or antagonistic interactions. Subspecies identification and genotypic resistance profiles were assessed using the GenoType NTM-DR assay. Of the isolates, 84.2% were identified as M. abscessus subsp. abscessus, 10.5% as M. abscessus subsp. massiliense, and 5.26% as M. abscessus subsp. bolletii. While no rrl (acquired macrolide resistance) or rrs (aminoglycoside resistance) mutations were detected, a functional erm41 (inducible macrolide resistance) gene was found in 73.6% of isolates. Synergistic effects were observed at rates of 84.2% for BDQ/VP, 57.9% for CLA/VP, 5.26% for BDQ/BER, and 31.5% for CLA/BER, with no antagonism identified. The BDQ/VP combination showed significantly greater synergy than BDQ/BER (p < 0.0005) and was superior to CLA/VP (p < 0.0005). Combinations with VP demonstrated significantly lower FICI values (p < 0.0005). Median fold increases in antimicrobial activity were four-fold with VP and two-fold with BER. In conclusion, the BDQ/VP combination emerged as the most effective regimen. These results highlight the synergistic potential of EPI-antimicrobial combinations and may inform the development of new therapeutic strategies for NTM infections.
- 11 October 2025
- Published by Springer Nature in Folia Microbiologica
- p. 1-8
Evaluation of the interaction and synergy potential of bedaquiline and clarithromycin in combination with efflux pump inhibitors in clinical isolates of Mycobacterium abscessus complex
Nontuberculous mycobacteria (NTM) cause difficult-to-treat pulmonary infections due to their high antimicrobial resistance. Among them, the Mycobacterium abscessus complex (MABC) is a major pathogen characterized by prolonged treatment courses and low success rates. This study investigated the combination effects of the antimicrobials bedaquiline (BDQ) and clarithromycin (CLA) with the efflux pump inhibitors (EPIs) verapamil (VP) and berberine (BER) in clinical MABC isolates. Nineteen MABC strains isolated from respiratory samples were analyzed using the checkerboard method, and fractional inhibitory concentration index (FICI) values were calculated to determine synergistic, indifferent, or antagonistic interactions. Subspecies identification and genotypic resistance profiles were assessed using the GenoType NTM-DR assay. Of the isolates, 84.2% were identified as M. abscessus subsp. abscessus, 10.5% as M. abscessus subsp. massiliense, and 5.26% as M. abscessus subsp. bolletii. While no rrl (acquired macrolide resistance) or rrs (aminoglycoside resistance) mutations were detected, a functional erm41 (inducible macrolide resistance) gene was found in 73.6% of isolates. Synergistic effects were observed at rates of 84.2% for BDQ/VP, 57.9% for CLA/VP, 5.26% for BDQ/BER, and 31.5% for CLA/BER, with no antagonism identified. The BDQ/VP combination showed significantly greater synergy than BDQ/BER (p < 0.0005) and was superior to CLA/VP (p < 0.0005). Combinations with VP demonstrated significantly lower FICI values (p < 0.0005). Median fold increases in antimicrobial activity were four-fold with VP and two-fold with BER. In conclusion, the BDQ/VP combination emerged as the most effective regimen. These results highlight the synergistic potential of EPI-antimicrobial combinations and may inform the development of new therapeutic strategies for NTM infections.
- 20 March 2025
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 30 (1) , 110-115
Pulmonary Tuberculosis Diagnosed with Xpert® MTB/RIF Ultra in Stool Specimen in an Infant: A Case Report
- 20 March 2025
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 30 (1) , 110-115
Pulmonary Tuberculosis Diagnosed with Xpert® MTB/RIF Ultra in Stool Specimen in an Infant: A Case Report